Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,300 | 1 | 88.1% |
| Food and Beverage | $311.34 | 13 | 11.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,345 | 3 | $0 (2024) |
| CSL Behring | $178.64 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $65.73 | 1 | $0 (2023) |
| Calliditas Therapeutics US Inc. | $22.14 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $103.28 | 5 | CSL Behring ($82.58) |
| 2023 | $2,508 | 9 | Novartis Pharmaceuticals Corporation ($2,324) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Immunology | ||||||
| 10/31/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Immunology | ||||||
| 08/14/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Immunology | ||||||
| 06/19/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Immunology | ||||||
| 12/14/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Immunology | ||||||
| 11/05/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $65.73 | General |
| 11/03/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $24.13 | General |
| 11/01/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Nephrology | ||||||
| 10/30/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Immunology | ||||||
| 09/01/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Immunology | ||||||
| 05/10/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Immunology | ||||||
| 04/20/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Consulting Fee | Cash or cash equivalent | $2,300.00 | General |
| 04/14/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 243 | 697 | $147,819 | $15,348 |
| 2022 | 7 | 421 | 1,186 | $253,454 | $27,056 |
| 2021 | 7 | 519 | 1,313 | $291,330 | $31,011 |
| 2020 | 7 | 382 | 856 | $193,936 | $20,454 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2023 | 45 | 356 | $54,824 | $7,865 | 14.3% |
| 88348 | Electron microscopy for diagnosis | Facility | 2023 | 48 | 49 | $56,301 | $2,890 | 5.1% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 49 | 190 | $16,150 | $1,744 | 10.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 52 | 52 | $12,844 | $1,480 | 11.5% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Facility | 2023 | 49 | 50 | $7,700 | $1,370 | 17.8% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2022 | 73 | 606 | $93,324 | $13,662 | 14.6% |
| 88348 | Electron microscopy for diagnosis | Facility | 2022 | 76 | 80 | $91,920 | $4,794 | 5.2% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2022 | 77 | 282 | $23,970 | $2,630 | 11.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 77 | 81 | $20,007 | $2,350 | 11.7% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Facility | 2022 | 77 | 82 | $12,628 | $2,292 | 18.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 23 | 26 | $5,486 | $698.79 | 12.7% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 18 | 29 | $6,119 | $629.20 | 10.3% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2021 | 76 | 623 | $95,942 | $14,349 | 15.0% |
| 88348 | Electron microscopy for diagnosis | Facility | 2021 | 96 | 98 | $112,602 | $6,004 | 5.3% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2021 | 97 | 318 | $27,030 | $3,033 | 11.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 96 | 98 | $24,206 | $2,885 | 11.9% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Facility | 2021 | 95 | 98 | $15,092 | $2,801 | 18.6% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2021 | 27 | 44 | $9,284 | $993.23 | 10.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2021 | 32 | 34 | $7,174 | $944.92 | 13.2% |
| 88350 | Antibody evaluation | Facility | 2020 | 43 | 340 | $51,744 | $7,960 | 15.4% |
| 88348 | Electron microscopy for diagnosis | Facility | 2020 | 67 | 68 | $78,132 | $4,179 | 5.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2020 | 72 | 73 | $18,031 | $2,225 | 12.3% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2020 | 71 | 231 | $19,635 | $2,223 | 11.3% |
| 88346 | Antibody evaluation | Facility | 2020 | 69 | 70 | $10,780 | $2,006 | 18.6% |
| 88341 | Special stained specimen slides to examine tissue | Facility | 2020 | 29 | 42 | $8,862 | $961.78 | 10.9% |
About Dr. Xin Zhou, MD
Dr. Xin Zhou, MD is a Anatomic Pathology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528037983.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Xin Zhou, MD has received a total of $2,611 in payments from pharmaceutical and medical device companies, with $103.28 received in 2024. These payments were reported across 14 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($2,300).
As a Medicare-enrolled provider, Zhou has provided services to 1,565 Medicare beneficiaries, totaling 4,052 services with total Medicare billing of $93,869. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Location Dallas, TX
- Active Since 03/16/2006
- Last Updated 12/18/2007
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1528037983
Products in Payments
- Hizentra (Biological) $178.64
- TARPEYO (Drug) $22.14
- Fabhalta (Drug) $20.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in Dallas
Dr. Olga Weinberg, M.d, M.D
Anatomic Pathology — Payments: $54,995
Dr. Kirthi Kumar, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $7,027
Richard Hopley, Md, MD
Anatomic Pathology — Payments: $5,797
Elizabeth Dole, M.d, M.D
Anatomic Pathology — Payments: $779.72
Donna Lager, M.d, M.D
Anatomic Pathology — Payments: $581.91
Rujuta Kanhere, M.d, M.D
Anatomic Pathology — Payments: $290.41